Ryan Savitz, EVP, CFO & Cbo: Dianthus Therapeutics DNTH Sell · Filed 04/01

Trade details

Type: Insider sale
Amount: $1,646,493.33
Shares · price: 19,469 sh · $84.57 a share
Held after: 7,232 sh
Stock: Dianthus Therapeutics DNTH
Person: Ryan SavitzEVP, CFO & Cbo
Trade date: 26/03/31
Filed: 26/04/01
Days to filing: 1 days

Sold 72.9% of holdings

Share of holding sold: 72.9%

Dianthus Therapeutics trades, last 26 weeks

What else happened in Dianthus Therapeutics around then

Filed or reported within 30 days of the trade day · 03/01~04/30

Ryan Savitz's recent trades

Ryan SavitzEVP, CFO & Cbo
Planned sale10b5-1 planDianthus Therapeutics
Planned sale10b5-1 plan
Dianthus Therapeutics
DNTH
$3.1M
31,249 sh
$3.1M
Filed 07/09
Traded 07/09
Ryan SavitzEVP, CFO & Cbo
Sell10b5-1 planDianthus Therapeutics
Sell10b5-1 plan
Dianthus Therapeutics
DNTH
$738.8K
8,224 sh
$738.8K
Filed 04/10
Traded 04/09
Ryan SavitzEVP, CFO & Cbo
Planned sale10b5-1 planDianthus Therapeutics
Planned sale10b5-1 plan
Dianthus Therapeutics
DNTH
$719.4K
8,224 sh
$719.4K
Filed 04/09
Traded 04/09
Ryan SavitzEVP, CFO & Cbo
Sell10b5-1 planDianthus Therapeutics
Sell10b5-1 plan
Dianthus Therapeutics
DNTH
$5M
59,800 sh
$5M
Filed 04/01
Traded 03/31
Ryan SavitzEVP, CFO & Cbo
Sell10b5-1 planDianthus Therapeutics
Sell10b5-1 plan
Dianthus Therapeutics
DNTH
$1.7M
21,825 sh
$1.7M
Filed 04/01
Traded 03/31